Secondly, ERK5 has a role in the epithelial-to-mesenchymal transition (EMT) [31], a process of cellular plasticity, aberrantly activated in cancer, that promotes tumor progression toward a malignant phenotype [32]. The gene discussed is MAPK7; the disease is cancer.